Disease areas
Disease areas
Multiple Myeloma
Multiple Myeloma
Lymphoma
.jpg?width=625&height=288&format=webp&quality=50)
Chronic Lymphocytic Leukemia
.jpg?width=625&height=288&format=webp&quality=50)
Waldenström macroglobulinemia
.jpg?width=625&height=288&format=webp&quality=50)
Mantelcellymfoom
Myeloid Leukemia
.jpg?width=625&height=288&format=webp&quality=50)
Myeloid Leukemia
Product portfolio in hematology
Imbruvica®
Imbruvica (ibrutinib) is a Bruton tyrosine kinase (BTK) inhibitor for the treatment of chronic lymphocytic leukaemia (CLL), mantle cell lymphoma (MCL) and Waldenström macroglobulinemia (WM). Discover scientific information, materials for you and your patients, therapy management and much more.
.png?width=544&height=250&format=webp&quality=50)
Darzalex®
Darzalex (daratumumab) is a targeted monoclonal antibody for the treatment of multiple myeloma (MM). Discover scientific information, materials for you and your patients, guidelines and much more.
.png?width=544&height=250&format=webp&quality=50)
CP-217996 - March 2021
© Janssen-Cilag NV 2021. This site is published by Janssen-Cilag NV which is solely responsible for its content. It is intended for Healthcare professionals in Belgium and Luxembourg.
